SCM
Suvretta Capital Management’s Sutro Biopharma STRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.63M | Sell |
6,488,324
-974,171
| -13% | -$695K | 0.14% | 61 |
|
|
2025
Q1 | $4.86M | Hold |
7,462,495
| – | – | 0.18% | 62 |
|
|
2024
Q4 | $13.7M | Buy |
7,462,495
+275,000
| +4% | +$506K | 0.47% | 49 |
|
|
2024
Q3 | $24.9M | Sell |
7,187,495
-521,195
| -7% | -$1.8M | 0.8% | 39 |
|
|
2024
Q2 | $22.6M | Buy |
7,708,690
+1,930,502
| +33% | +$5.66M | 0.83% | 38 |
|
|
2024
Q1 | $32.6M | Hold |
5,778,188
| – | – | 1.21% | 27 |
|
|
2023
Q4 | $24.8M | Sell |
5,778,188
-105,505
| -2% | -$453K | 1.12% | 31 |
|
|
2023
Q3 | $20.4M | Hold |
5,883,693
| – | – | 1.1% | 29 |
|
|
2023
Q2 | $27.4M | Buy |
5,883,693
+194,607
| +3% | +$905K | 1.46% | 24 |
|
|
2023
Q1 | $26.3M | Buy |
5,689,086
+123,987
| +2% | +$573K | 1.11% | 28 |
|
|
2022
Q4 | $45M | Buy |
5,565,099
+545,099
| +11% | +$4.4M | 1.89% | 23 |
|
|
2022
Q3 | $27.9M | Buy |
5,020,000
+375,000
| +8% | +$2.08M | 1.16% | 33 |
|
|
2022
Q2 | $24.2M | Buy |
4,645,000
+912,600
| +24% | +$4.75M | 0.92% | 38 |
|
|
2022
Q1 | $30.7M | Buy |
3,732,400
+1,294,605
| +53% | +$10.6M | 0.94% | 37 |
|
|
2021
Q4 | $36.3M | Buy |
2,437,795
+204,100
| +9% | +$3.04M | 0.7% | 38 |
|
|
2021
Q3 | $42.2M | Buy |
2,233,695
+518,314
| +30% | +$9.79M | 0.71% | 38 |
|
|
2021
Q2 | $31.9M | Buy |
1,715,381
+430,405
| +33% | +$8M | 0.48% | 48 |
|
|
2021
Q1 | $29.2M | Buy |
1,284,976
+249,567
| +24% | +$5.68M | 0.43% | 49 |
|
|
2020
Q4 | $22.5M | Sell |
1,035,409
-134,757
| -12% | -$2.93M | 0.32% | 52 |
|
|
2020
Q3 | $11.8M | Buy |
1,170,166
+267,366
| +30% | +$2.69M | 0.21% | 49 |
|
|
2020
Q2 | $7.01M | Buy |
902,800
+821,800
| +1,015% | +$6.38M | 0.15% | 54 |
|
|
2020
Q1 | $826K | Buy |
+81,000
| New | +$826K | 0.02% | 54 |
|